RESUMO
We investigated the presence of biochemically modified plasma lipoproteins as pathologic factor for coronary heart disease in 15 patients with angina pectoris (CHD-P) vs 20 normal subjects (N). Decreased HDL were the most significant pathological feature present in P over 66 years old, while, P under 66 had, in addition to low HDL-Cholesterol (HDL-C), high levels of plasma cholesterol (C), LDL-Cholesterol (LDL-C), and lipid peroxides (TBARS), together with the presence of desialylated LDL and VLDL. We demonstrated by statistic analysis that these risk factors are correlated: high plasma C with a more pronounced imbalance between LDL and HDL, which, in turn, is associated with high TBARS levels, and also with circulating desialylated VLDL; high plasma TBARS values with desialylated LDL. We detected an increased level of autoantibodies towards autologous LDL and VLDL, in P vs N. The level of autoantibodies anti-LDL correlated with LDL-C level and with LDL desialylation, thus modified circulating LDL being most probably atherogenic. Circulating anti-LDL autoantibodies together with the low level of HDL might contribute to acceleration and aggravation of the atherosclerotic process.
Assuntos
Doença das Coronárias/sangue , Lipoproteínas/sangue , Adulto , Idoso , Idoso de 80 Anos ou mais , Angina Pectoris/sangue , Autoanticorpos/sangue , Colesterol/sangue , Jejum/sangue , Humanos , Modelos Lineares , Lipoproteínas/imunologia , Masculino , Pessoa de Meia-Idade , Fatores de RiscoAssuntos
Bloqueadores dos Canais de Cálcio/uso terapêutico , Hipertensão/tratamento farmacológico , Bloqueadores dos Canais de Cálcio/efeitos adversos , Bloqueadores dos Canais de Cálcio/farmacologia , Humanos , Hipertrofia Ventricular Esquerda/tratamento farmacológico , Rim/efeitos dos fármacos , Músculo Liso Vascular/efeitos dos fármacosRESUMO
The paper reports on the study of 1457 patients with acute myocardial infarct (Ami) admitted in the word of the cardiac intensive care of the clinic for 10.5 years. The general mortality was of 21.2% and the sudden death (defined as such when appeared suddenly within less than 1 hour from the onset of the acute symptoms, but after 24 hours from the onset of AMI in a patient apparently equilibrated) appeared in 114 patients who were examined postmortem (43.3% of the total of the deaths). The main causes of the SD was rupture of the myocardium (28.8% of the general mortality), primary ventricular fibrillation (22.0%) and thromboembolic phenomena (17.8%). The sudden death by rupture of the myocardium appeared in a first AMI, usually large and was not helped by the anticoagulant treatment or by other therapy. Primary ventricular fibrillation appeared during the first week from the onset and was favoured by the ventricular hyperexcitability and active myocardial ischemia (which were not specific). Xyline (only more than 2 mg/min) and amiodarone gave a good protection. The sudden death by systemic thromboembolization appeared almost only in the antero-lateral myocardial infarcts, 5-8 days after the onset. The appearance of a small flow syndrome "sine materia" with or without association of some recurrent arrhythmias was suggested. Efficient anticoagulation prevented systemic thromboembolization and, to a smaller extent to pulmonary thromboembolization.
Assuntos
Morte Súbita Cardíaca/epidemiologia , Mortalidade Hospitalar , Infarto do Miocárdio/mortalidade , Causas de Morte , Morte Súbita Cardíaca/patologia , Ruptura Cardíaca Pós-Infarto/mortalidade , Ruptura Cardíaca Pós-Infarto/patologia , Humanos , Infarto do Miocárdio/complicações , Infarto do Miocárdio/patologia , Embolia Pulmonar/mortalidade , Embolia Pulmonar/patologia , Estudos Retrospectivos , Fatores de Risco , Romênia/epidemiologia , Tromboembolia/mortalidade , Tromboembolia/patologia , Fatores de Tempo , Fibrilação Ventricular/mortalidade , Fibrilação Ventricular/patologiaAssuntos
Doença das Coronárias/complicações , Insuficiência da Valva Mitral/etiologia , Cordas Tendinosas , Doença das Coronárias/diagnóstico , Doença das Coronárias/fisiopatologia , Doença das Coronárias/cirurgia , Ecocardiografia Doppler , Ruptura Cardíaca/diagnóstico , Ruptura Cardíaca/etiologia , Ruptura Cardíaca/fisiopatologia , Ruptura Cardíaca/cirurgia , Humanos , Valva Mitral/fisiopatologia , Insuficiência da Valva Mitral/diagnóstico , Insuficiência da Valva Mitral/fisiopatologia , Insuficiência da Valva Mitral/cirurgia , Músculos Papilares , PrognósticoAssuntos
Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Hipertensão/tratamento farmacológico , Inibidores da Enzima Conversora de Angiotensina/efeitos adversos , Inibidores da Enzima Conversora de Angiotensina/farmacocinética , Inibidores da Enzima Conversora de Angiotensina/farmacologia , Hemodinâmica/efeitos dos fármacos , Humanos , Hipertensão/fisiopatologia , Relação Estrutura-AtividadeAssuntos
Nitratos/farmacologia , Vasodilatadores/farmacologia , Animais , Canais de Cálcio/efeitos dos fármacos , Canais de Cálcio/enzimologia , ATPases Transportadoras de Cálcio/metabolismo , Tolerância a Medicamentos , Técnicas In Vitro , Músculo Liso Vascular/efeitos dos fármacos , Músculo Liso Vascular/enzimologia , Sarcolema/efeitos dos fármacos , Sarcolema/enzimologia , Estimulação Química , SuínosAssuntos
Angina Pectoris/epidemiologia , Infarto do Miocárdio/complicações , Adulto , Idoso , Idoso de 80 Anos ou mais , Angina Pectoris/tratamento farmacológico , Angina Pectoris/etiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prognóstico , Recidiva , Estudos Retrospectivos , Fatores de TempoAssuntos
Hipertensão/tratamento farmacológico , Antagonistas Adrenérgicos beta/uso terapêutico , Inibidores da Enzima Conversora de Angiotensina , Anti-Hipertensivos/uso terapêutico , Bloqueadores dos Canais de Cálcio/uso terapêutico , Diuréticos/uso terapêutico , Quimioterapia Combinada , Humanos , Hipertensão/sangue , Inibidores de Proteases/uso terapêutico , Vasodilatadores/uso terapêuticoRESUMO
In 25 adult diabetic patients, tissue fragments from myocardium were removed at necropsy and processed routinely. The morphometrical analysis was made using eye-piece ocular micrometer on a definite microscopic area. The arteriolar wall thickness increased from 5.10 mu +/- 1.71 in control group to 7.37 mu +/- 1.98 in the diabetic heart. The arterioles number decreased from 5.82/mm2 +/- 0.54 in the nondiabetics to 2.51/mm2 +/- 0.65 in the diabetic heart. The mean arteriolar diameter increased from 24.61 mu +/- 7.7 in the control group to 29.45 mu +/- 8.25 in the diabetic myocardium. The mean capillary diameter increased from 4.09 mu +/- 0.63 to 5.69 mu +/- 1.34 in diabetics. The capillaries number/mm2 decreased from 6.98 +/- 1.55 in the nondiabetics to 4.39 +/- 1.54 in diabetic patients. All differences, less the mean arteriolar diameter, are statistically significant. The following microscopical aspects were found in the small intramural coronary arteries: proliferation of endothelial cells with focal protuberances leading to partial narrowing of the lumen; increased thickness of the arteriolar wall due to fibrosis and accumulation of neutral mucopolysaccharides; alterations of elastic fibers. Frequently small areas of perivascular fibrosis and isolated foci of myocytolysis were found as well. These results suggest that the arteriolar impairment, especially the thickening of the arteriolar wall, could play a role in the pathogenesis of diabetic cardiomyopathy.